|
The optimum reactive temprature was 75℃,and the re combinant enzyme was more stable on the temperature of 25～55℃.
|
|
|
重组酶反应的最适温度为75℃,酶活稳定的温度范围为25～55℃。 |
|
The optimum temperature was 30 ℃,but not stable at temperature above 30 ℃ The optimum pH for the enzyme activity was 7.5.Its activity can be stimulated by K+,Na+,Ca2+ and Mn2+,but strongly inhibited by Hg2+,Zn2+ and Cu2+.
|
|
|
酶反应最适pH为7.5,最适反应温度为30℃,30℃下保温30 min,酶活力基本不变,高于30℃酶活力则迅速下降; K+、Na+、Ca2+、Mn2+对酶活性有促进作用,Hg2+、Zn2+和Cu2+等对酶有抑制作用。 |
|
The pathological characteristics and dissemination mechanism of primary B cell lymphoma of the gastrointestinal tract
|
|
|
胃肠道原发B细胞性淋巴瘤的病理学特征及播散机制 |
|
The patients experienced the drug-induced liver diseases in 2~4 weeks and within 2 weeks after the administration of drugs(66% vs.26.2%). The most diagnoses of the liver diseases included acute hepatocellular hepatitis(62.1%) and jaundice(59.2%).
|
|
|
用药2~4周出现肝损害者最常见(66%),2周内者次之(26.2%),临床以急性肝炎肝细胞型最常见(62.1%),其中5例出现暴发性肝功能衰竭(4.9%); |
|
The percentage of Ki-67 positive cells was significantly lower in patients with ALL, whose white blood cell were less than 30×10 9/L at initial diagnosis.
|
|
|
初发时白细胞 <30× 10 9/ L的急性淋巴细胞性白血病病例 ,Ki- 6 7阳性率明显降低 (P <0 .0 1)。 |
|
The peripheral T-lymphocyte subpopulations and red-cell immunology were concerned with the curative effects of the patients with laryngeal carcinoma (P<0. 05-0. 01).
|
|
|
T淋巴细胞亚群、红细胞免疫等指标均与疗效有关(P<0.05-0.01); |
|
The pharmacokinetics and bioavailability were compared. RESULTS The main pharmcokinetic parameters after ig or iv a single dose of 5mg HZ08 were as follows: Cmax (384.3±40.4) and (5.7±2.3) ng·mL-1;
|
|
|
结果静脉注射和灌胃5mgHZ08后血药浓度水平有极其显著性差异,主要药动学参数如下:Cmax分别为(384.3±40.4)和(5.7±2.3)ng·mL-1; |
|
The pharmacokinetics and distribution of ditiocarb sodium intravenously injected with l00mg·kg-1 of DTC (DTC) in mice were studied. The excretion in rats after iv administra-tion of 50mg·kg-1 of DTC was also investigated.
|
|
|
本文研究了小鼠iv DTC100 mg·kg~(-1)的体内药代动力学和组织分布特征及大鼠iv DTC50mg·kg~(-1)的排泄情况。 |
|
The pharmacokinetics of aspirin sustained-release tablets in health volunteers
|
|
|
阿司匹林缓释片健康人体药动学 |
|
The pharmacokinetics of ceftazidime in the burned patients
|
|
|
应用头孢噻甲羧肟后烧伤病人体内的药代动力学改变 |
|
The pharmacokinetics of propafenone in old aged arrhythmic patients
|
|
|
老年心律失常病人的普罗帕酮药物动力学 |
